Stem cells may be especially attractive as COVID-19 treatments since early passages do not display the SARS-CoV-2 receptor (angiotensin-converting enzyme 2 (ACE2)), rendering them resistant to infection [14]. This evidence concerns the gene ACE2 and COVID-19.